Innovating Vaccines
ImmBio is developing next-generation vaccines targeting a number of serious infectious diseases, based on its proprietary technologies.
Find out more
About us
ImmBio has experienced executives and staff based in state of the art facilities at the Babraham Research Campus, Cambridge UK. ImmBio develops innovative vaccines to establish broad immunity.
Find out more
Technology
Our vaccines protect by targeting antigens to dendritic cells. This is achieved using two approaches "ImmBioVax" our lead technology and "ImmunoBodies".
Find out more
Pipeline
Our pipeline includes development vaccines against meningitis, TB and pneumococcal disease. ImmBio selects new opportunities where its technologies are most effective.
Find out more
Partner
ImmBio's approach is to develop innovative vaccines in partnership and to license once an appropriate developmental milestone is achieved. Contact ImmBio to find out more.
Find out more
